GL1X · GenesisL1 explorer

MolNFT v1 · #38636 · protein

Crystal structure of PTP1B with monocyclic thiophene inhibitor

2H4G · Tyrosine-protein phosphatase non-receptor type 1: “Crystal structure of PTP1B with monocyclic thiophene inhibitor”. X-ray diffraction, 1 ligand (694), 1 pocket (best druggability 0.50). MolNFT v1 #38636 on GenesisL1: 3D structure…

PDB
2H4G
Type
protein
Length
297 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein phosphatase non-receptor type 1
EC
3.1.3.48
UniProt
P18031
Ligands
694
Pockets
1 · best druggability 0.50

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48)protein29736% helix, 20% strandP18031

Ligands and binding sites

  • 694 · 4-bromo-3-(carboxymethoxy)-5-(4-hydroxyphenyl)thiophene-2-carboxylic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1780.500.8315694

Compared structures

  • 2H4G · Crystal structure of PTP1B with monocyclic thiophene inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.